Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2003
06/26/2003US20030118608 Comprising Lelystad Agent in a live, attenuated, dead, or recombinant form
06/26/2003US20030118604 Comprising the 2-45 amino acid sequence of the N-terminal end of the core or nucleocapsid (p21) protein of the hepatitis C virus (HCV), excluding any protein or peptide compound comprising the N-terminal end
06/26/2003US20030118593 Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
06/26/2003US20030118592 Binding domain-immunoglobulin fusion proteins
06/26/2003US20030118591 Treatment of severe anthrax infection particularly inhalation pneumonia or gastrointestinal anthrax antigen by passive transfer to infected patients of plasma or derivatives, such as gammaglobulins or antibodies, against bacillus anthracis
06/26/2003US20030118588 Compound comprising an agonist anti-4-1BB antibody, or fragment thereof which stimulates the 4-1BB receptor; for treating tumors or infectious diseases
06/26/2003US20030118587 Hepatocyte growth factor receptor antagonists and uses thereof
06/26/2003US20030118584 Administration of antibody combining site-containing molecules that specifically bind to specific class of reversibly-bound GPIIb/IIIa fibrinogen receptor antagonist compounds
06/26/2003US20030118583 Performing polypeptide exposure to urea in the presence of a glycine containing solution to deactivate viral contaminants
06/26/2003US20030118546 Genetic engineering; polypeptides; antitumor agent
06/26/2003CA2471570A1 Focussed antibody technology
06/26/2003CA2467732A1 Novel human proteins, polynucleotides encoding them and methods of using the same
06/26/2003CA2459661A1 Insect g protein-coupled receptor genes and uses thereof
06/26/2003CA2456210A1 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/26/2003CA2412627A1 Genes and proteins involved in the biosynthesis of lipopeptides
06/25/2003EP1321772A1 Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine
06/25/2003EP1321478A2 Antibody against Streptococcus mutans and its use in an immunoassay
06/25/2003EP1321477A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
06/25/2003EP1321476A2 Binding protein
06/25/2003EP1321466A1 Haptens, immunogens, antibodies and conjugates for 2-oxo-3-hydroxy LSD
06/25/2003EP1320756A1 Novel antibody, immunoassay and method for prostate cancer detection
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320613A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/25/2003EP1320605A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22 and uses thereof
06/25/2003EP1320601A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320585A2 Oxidoreductases
06/25/2003EP1320584A2 Transferases
06/25/2003EP1320552A1 Method for producing human anti-thymocyte immunoglobulins
06/25/2003EP1320551A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320549A2 Pumpcn compositions and uses thereof
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320546A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
06/25/2003EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
06/25/2003EP1320382A2 Novel methods for inhibition of viral infection
06/25/2003EP1320380A2 Tubulin based vaccine against trypanosomiasis
06/25/2003EP1320376A2 Treatment of prostate cancer
06/25/2003EP1320351A2 Methods of preparing immune globulin and uses thereof
06/25/2003EP0744958B1 Polyclonal antibody libraries
06/25/2003EP0618969B1 Composite antibodies of human subgroup iv light chain capable of binding to tag-72
06/25/2003CN1426468A KCNB: novel potassium channel protein
06/25/2003CN1426467A Thrombopoietin receptor modulating peptide
06/25/2003CN1426423A Humanized antibodies that sequester amyloid beta peptide
06/25/2003CN1426421A Tumour-specific animal proteins
06/25/2003CN1426307A 蛋白质 Protein
06/25/2003CN1426306A Method and compositions for impairing multiplication of HIV-1
06/25/2003CN1425768A Polypeptide-beta lactamase-9.02 and polynucleotide for encoding such polypeptide
06/25/2003CN1425767A Polypeptide-protein-8.91 containing indole-3-glycero phosphate synthetase structure domain and polynucleotide for encoding such polypeptide
06/25/2003CN1425689A Polypeptide-humand big protem 1196-31.79 and polynucleotide for encoding such polypeptide
06/25/2003CN1425688A Polypeptide-transcription factor protein-9.35 and polynucleotide for encoding such polypeptide
06/25/2003CN1425687A Polypeptide-protein-70.95 containing actin binding structural domain and polynucleotide for encoding such polypeptide
06/25/2003CN1425686A Polypeptide-glycoprotein-9.02 and polynucleotide for encoding such polypeptide
06/25/2003CN1425685A Polypeptide-human protein-9.35 containing glycoprotein structural domain and polynucleotide for encoding such polypeptide
06/25/2003CN1425684A Polypeptide-human reverse transcription transposition 40 protein-12.76 and polynucleotide for encoding such polypeptide
06/25/2003CN1425683A Polypeptide-flavoprotein subunit-9.68 and polynucleotide for encoding such polypeptide
06/25/2003CN1425682A Polypeptide-protein-11.99 containing ribosomal protein L16 structural domain and polynucleotide for encoding such polypeptide
06/24/2003US6583167 Methods and kits for treating and diagnosing leiomyomas
06/24/2003US6583113 Additional smooth muscle relaxant and platelet inhibitory capabilities.
06/24/2003US6583112 Gene products related to werner's syndrome
06/24/2003US6582959 Antibodies to vascular endothelial cell growth factor
06/24/2003US6582957 Lipoxygenase proteins and polynucleotides encoding the same
06/24/2003US6582945 Immunological control of β-amyloid levels in vivo
06/24/2003US6582935 Isolated nucleic acid molecules encoding human aspartate aminotransferase protein and uses thereof
06/24/2003US6582926 Solid support for use as analytical tool in genetic engineering
06/24/2003US6582925 Desaturase antigen of mycobacterium tuberculosis
06/24/2003US6582915 Production of anti-self bodies from antibody segment repertories and displayed on phage
06/24/2003US6582913 Detection of nucleotide sequence polymorphism; obtain nucleotide sequences sampple, determine nucleotide sequence, compare to control, detect adjustment in nucleotide sequences
06/24/2003US6582910 WbpP and method for assay of WbpP
06/24/2003US6582909 Genotyping biological sample; obtain sample, extract nucleotide sequence, sequence, compare to control, detect adjustments in sequences, score
06/24/2003US6582706 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS
06/24/2003US6582705 Acellular antibordetella vaccine
06/24/2003US6582703 Medical diagnosis; amplification primers; genetic engineering
06/24/2003US6582700 Linear antigen supporting units
06/24/2003US6582699 Combination of outer-polysaccharides extracted from Brucella comprises "A" outer-polysaccharide and "M" outer-polysaccharide and "R" protein antigens.
06/24/2003US6582698 Treatment method
06/24/2003CA2171544C Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
06/19/2003WO2003050531A2 Method for displaying loops from immunoglobulin domains in different contexts
06/19/2003WO2003050502A2 Prospective identification and characterization of breast cancer stem cells
06/19/2003WO2003050301A2 Susceptibility locus for schizophrenia
06/19/2003WO2003050287A2 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/19/2003WO2003050283A2 A structure for presenting desired peptide sequences
06/19/2003WO2003050265A2 Compositions and methods for normalizing assays
06/19/2003WO2003050260A2 Streptavidin expressed gene fusions and methods of use thereof
06/19/2003WO2003050258A2 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003WO2003050257A2 Targeting leukemia cells
06/19/2003WO2003050255A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003WO2003050236A2 Human genes and gene expression products isolated from human prostate
06/19/2003WO2003050142A1 Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides
06/19/2003WO2003050140A1 Tumor antigens
06/19/2003WO2003049773A1 Methods for inhibiting ocular processes
06/19/2003WO2003049755A1 Enhancement of immune responses by 4-1bb-binding agents
06/19/2003WO2003049704A2 Antibodies to treat cancer
06/19/2003WO2003049694A2 Methods of therapy for non-hodgkin's lymphoma
06/19/2003WO2003049684A2 Pseudo-antibody constructs
06/19/2003WO2003049673A2 Methods and compositions for control of bone formation via modulation of sympathetic tone
06/19/2003WO2003049602A2 Diagnostic methods for protein profiling
06/19/2003WO2003035681A3 Mycobacterial genes down-regulated during latency
06/19/2003WO2002094864A3 Human cdnas and proteins and uses thereof
1 ... 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 ... 1494